相关实验视频
Updated: Jul 14, 2025

10:37
Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
9.6K
通过使用奥马利祖马布成功对帕克利塔塞尔脱敏化
Natalia Barreras1, Alicia Gómez-López2, Marcela Valverde2
1Pharmacy Service, Hospital Universitario Fundacion Jimenez Diaz, Madrid, Spain natalia.barreras@quironsalud.es.
European journal of hospital pharmacy : science and practice
|October 5, 2023
概括
这项案例研究表明,奥马利祖马布成功使患有三阴性乳腺癌的患者在无敏化失败后能够接受帕克利塔塞尔化疗. 奥马利祖马布是对化疗药物过敏反应的潜在治疗方法.
科学领域:
- 在瘤学瘤学.
- 过敏和免疫学 过敏和免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕克利塔塞尔是治疗三阴性乳腺癌的关键化疗剂.
- 过敏反应,包括过敏反应,可能会使帕克利塔塞尔治疗复杂化.
- 标准的快速药物脱敏 (RDD) 协议可能并不总是成功.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
317
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
317
Desensitization and Tachyphylaxis
1.8K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.8K

